Annotation Detail

Information
Associated Genes
KRAS
Associated Variants
KRAS EXON 2 MUTATION
KRAS EXON 2 MUTATION
Associated Disease
pancreatic carcinoma
Source Database
CIViC Evidence
Description
KRAS exon 2 was mutated in 121 of 173 patients with advanced pancreatic cancer. Patients with KRAS wildtype had an improved OS (HR 1.68, p = 0.005).
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/917
Gene URL
https://civic.genome.wustl.edu/links/genes/30
Variant URL
https://civic.genome.wustl.edu/links/variants/75
Rating
3
Evidence Type
Prognostic
Disease
Pancreatic Carcinoma
Evidence Direction
Supports
Evidence Level
B
Clinical Significance
Poor Outcome
Pubmed
23435671
Drugs